TheStreet noted that Galena Biopharma Inc.'s (Nasdaq: GALE) financing deal
with Lincoln Park Financial contained highly unfavorable terms for the
struggling biopharmaceutical. The stock price fell 18 cents to close at $1.89.
Galena's financing deal questioned
November 24, 2014 at 16:02 PM EST